Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BY101298 Capsules plus radiotherapy in malignant solid tumors
CTR20240701Phase 2Terminated
- Sponsor
- Baiyu Pharmaceutical
- Start
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of BY101298 in Non-hematologic malignancy, sponsored by Baiyu Pharmaceutical. Started Mar 2024; status: terminated.
02
Drugs
BY101298
03
Conditions
Non-hematologic malignancy
Beyond the preview
Go deeper on CTR20240701.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20240701.